Learn More
STEMCELL Technologies R848
Immune modulator; Inhibits TLR7 and TLR8
Brand: STEMCELL Technologies 73784

Description
- R848 is an imidazoquinoline and agonist of Toll-like receptors (TLRs) 7 and 8
- It mimics the pathogen-associated molecular patterns that activate immune cells through TLR7 and TLR8, and thereby acts as an immune-response modifier
- It demonstrates potent anti-tumor and anti-viral properties (IC50 = 4.2 μM; Seganish et al.) which appear to be mediated predominantly through the induction of cytokines, including interferon (IFN)-α and interleukin (IL)-12 due to stimulation of monocytes, macrophages, and dendritic cells (Bernstein et al.; Hattermann et al.; Nian et al.)
Specifications
144875-48-9 | |
50 mg | |
≥98% |
Resiquimod; S 28463 | |
C17H22N4O2 |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.